Article Listing - Actelion's ponesimod does well in mid-stage psoriasis trial

FIRST QUARTER LOSS AT ALLELIX

17 February 1992

Canadian biopharmaceutical concern Allelix has reported a loss of around C$300,000 ($254,790) for the first quarter ended November 30, 1991....

RHONE-POULENC UNITS IN AIDS JV

17 February 1992

Rhone-Poulenc Rorer, the Franco-American health care concern and the Pasteur Merieux Connaught Group, a vaccines manufacturer which is owned by...

BELMAC CORP LOOKS TO USA

17 February 1992

Belmac Corp, a small pharmaceutical company which was set up by French chemist Jean-Francois Rossignol, is aiming to become a...

PFIZER INVESTS IN NEUROGEN RESEARCH

17 February 1992

US health care concern, Pfizer, has committed itself to providing around $50 million over the next five years for research...

USTR INVITES COMMENTS ON INDIAN PATENT ACTION

17 February 1992

The US Trade Representative, Carla Hills, has intensified her country's pressure on India over the issue of intellectual property rights...

MORTALITY BENEFIT WITH GYNEX' OXANDRIN

17 February 1992

Gynex Pharmaceuticals Inc has reached an agreement with the US Department of Veterans Affairs, giving it access to and use...

MYLAN CLAIMS FDA DISCRIMINATION

17 February 1992

The US Food and Drug Administra-tion is allegedly withholding appr-oval of drugs for Mylan Laborat-ories because the company revealed malpractices...

US PRICE DISCOUNTING

17 February 1992

Glaxo Inc has announced it will offer price discounts to US public health clinics serving the poor, in order to...

HIV POPULATIONS "ARE STABILIZING"

17 February 1992

By 2005, the world market for anti-HIV compounds, excluding treatments for opportunistic infections, will have reached a level of $725...

PHILIPPINES DOUBT OVER CEPT SCHEME

17 February 1992

The pharmaceutical industry in the Philippines may not yet be strong enough to compete with the industries of the other...

Showing 94781-94790 of 95365 articles

Go to beginningPreviousNextGo to end